Clusterin at the Ocular Surface
眼表面的聚集蛋白
基本信息
- 批准号:9755442
- 负责人:
- 金额:$ 55.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-01 至 2021-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdverse effectsAffectAgingAnti-inflammatoryApicalBasic ScienceBindingBiochemicalBiological AssayBiological Response Modifier TherapyBlindnessCellsCharacteristicsClinicalContact LensesCorneaCyclosporineCytoprotectionDataDiseaseDropsDry Eye SyndromesEnvironmentEnvironmental ExposureEpithelialEpitheliumExperimental ModelsEyeGalactose Binding LectinGalectin 3GenesGeneticGlycocalyxGlycoproteinsHumanHydration statusIn VitroInflammationInflammatoryJournalsKnockout MiceKnowledgeLeftLightLiquid substanceLubricationMMP9 geneMeasurementMedicalMedicineMethodsModelingMolecularMusNatureOperative Surgical ProceduresOphthalmologic Surgical ProceduresPainPathway interactionsPatientsPenetrationPeptidesPharmaceutical PreparationsPositioning AttributePropertyProteinsProteolysisPruritusPublishingRednessResearchResearch PersonnelRoleSquamous MetaplasiaStressStructureSurfaceSymptomsTherapeuticTissuesUnited States Food and Drug AdministrationUnited States National Institutes of HealthWorkcorneal epitheliumcorneal scareye drynessin vivoinflammatory milieuinnovationintercalationmouse modelnovelnovel strategiesnovel therapeuticsocular surfacepreventproteostasisresponsesealsulfated glycoprotein 2tear proteins
项目摘要
7. PROJECT SUMMARY/ ABSTRACT
Dry eye syndrome is a common affliction of the eye that affects millions of people. Dry eye is brought on by
aging, eye surgery or environmental exposure and is also an adverse effect of contact lens wear, and topical
eye medications. Symptoms include pain, burning, itching, redness, sensitivity to light and other discomfort. If
left untreated, severe cases may result in vision loss due to corneal scarring. New research from this research
team, recently published in the NIH-supported journal PLOS ONE, suggests a new approach to treating dry
eye. Using an experimental mouse model, the researchers found that the natural tear protein known as
clusterin selectively binds to the ocular surface barrier disrupted by desiccating stress in an all-or-none
manner, while also preventing further damage. Known properties of clusterin suggest it may further protect
against the upstream effects of inflammatory cascade activation and subsequent squamous metaplasia. The
proposed research will investigate this previously unrecognized, endogenous protective mechanism. The
planned studies make use of the mouse experimental model and a quantitative functional assay for ocular
surface barrier disruption, and take advantage of mouse genetics. The specific aims are: 1) to determine the
molecular nature of clusterin intercalation into the ocular surface glycocalyx, and how it might relate to the all-
or-none effect; 2) to document the role of clusterin in anti-proteolysis, the effects of proteolysis on the capacity
for clusterin binding, and the relationship between the proteolytic and clusterin pathways; 3) to define the
endogenous clusterin protection pathway and its role in maintaining an anti-inflammatory environment at the
ocular surface. The impact of this research will be new basic science knowledge about the ocular surface
barrier, how it is altered in disease, and mechanisms of protection by clusterin. The results will set the stage for
clinical innovation.
7.项目总结/摘要
干眼症是一种常见的眼部疾病,影响数百万人。干眼症是由
老化、眼科手术或环境暴露,并且也是接触透镜佩戴的不利影响,
眼科药物症状包括疼痛、灼热、瘙痒、发红、对光敏感和其他不适。如果
如果不进行治疗,严重的病例可能会由于角膜瘢痕而导致视力丧失。这项研究的新成果
最近发表在NIH支持的期刊PLOS ONE上的一个研究小组提出了一种治疗干燥的新方法。
眼睛研究人员使用实验小鼠模型发现,
丛生蛋白选择性地结合到被干燥应激破坏的眼表屏障上,
同时也防止了进一步的伤害。丛生蛋白的已知特性表明它可以进一步保护
对抗炎症级联激活和随后的鳞状上皮化生的上游效应。的
拟议的研究将调查这种以前未被认识到的内源性保护机制。的
计划中的研究利用小鼠实验模型和眼部功能的定量测定,
表面屏障破坏,并利用小鼠遗传学。具体目标是:1)确定
clusterin嵌入眼表面糖萼的分子性质,以及它如何与所有的
或无影响; 2)记录丛生蛋白在抗蛋白水解中的作用,蛋白水解对细胞增殖能力的影响,
clusterin结合,以及蛋白水解和clusterin途径之间的关系; 3)定义
内源性丛生蛋白保护途径及其在维持抗炎环境中的作用
眼表这项研究的影响将是关于眼表的新的基础科学知识
屏障,它是如何在疾病中改变的,以及丛生蛋白的保护机制。结果将为
临床创新
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
M. Elizabeth Fini其他文献
M. Elizabeth Fini的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('M. Elizabeth Fini', 18)}}的其他基金
Mitochondria and Mustard Damage at the Ocular Surface
眼表的线粒体和芥末损伤
- 批准号:
10708498 - 财政年份:2023
- 资助金额:
$ 55.67万 - 项目类别:
Dynasore Analogues for Ocular Surface Protection
用于眼表保护的 Dynasore 类似物
- 批准号:
10310762 - 财政年份:2019
- 资助金额:
$ 55.67万 - 项目类别:
Dynasore Analogues for Ocular Surface Protection
用于眼表保护的 Dynasore 类似物
- 批准号:
10004039 - 财政年份:2019
- 资助金额:
$ 55.67万 - 项目类别:
Protection and Treatment of the Ocular Surface Barrier
眼表屏障的保护和治疗
- 批准号:
9334035 - 财政年份:2017
- 资助金额:
$ 55.67万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 55.67万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 55.67万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 55.67万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 55.67万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 55.67万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 55.67万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 55.67万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 55.67万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 55.67万 - 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
- 批准号:
RGPIN-2018-04753 - 财政年份:2022
- 资助金额:
$ 55.67万 - 项目类别:
Discovery Grants Program - Individual